Story not found
← Return to briefingTexas is moving forward with clinical trials for ibogaine psychedelic. The state had initially sought assistance from a drug company but was unable to find a partner. As a result, Texas will now be conducting its own trials.
Further information on the trials can be found through the Texas Standard. Details on the scope and timeline of the trials are not specified, but the Texas Standard is a source for more information on this development in Texas.
This preview is provided by The Woodlands News. Full article available at .
Recent coverage curated from local and regional sources.
Gerardo Gonzalez is accused of causing severe injuries to a 2-year-old girl, and his bond was set at $1 million. According to court document…
Officers said the driver, who was in a small white sedan, took off without helping.
Iranian leadership published a new list of its demands before Tehran would allow the Strait of Hormuz to open again.
Police said the victim's father called 911, alert police to the stabbing Friday night.
Police are asking for the public’s help identifying three persons of interest in the deadly shooting of Floydrick Washington, who was killed…
HOUSTON (AP) - A 2-year-old girl whose parents sued a Texas hospital to prevent it from testing if she was brain-dead after she drowned in a…
Scattered thundershowers will again pop up on Saturday and Sunday afternoons, and those rain chances will climb even more Monday as tropical…
A couple approached law enforcement at a Spring gas station for help with an unresponsive two-year-old. An investigation determined the moth…
The suspect's father called 911 reporting that he and wife had been stabbed Friday night.
The NHC is monitoring a tropical wave in the eastern Atlantic with a 20% chance of development.
Police said a man died after accidentally shooting himself in the stomach during an argument with his sister.
The Trump administration is once again trying to limit who can become an American, with a pair of executive orders issued this week that att…
Free weekly digest. Local news that actually matters — no spam, no clickbait, easy unsubscribe.
By subscribing you agree to our privacy policy. We never sell your data.